Press Releases

• Takes over the new role effective July 1, 2023

• The company introduced a new production line at the Bengaluru facility to manufacture Magnetic Resonance Imaging (MRI) machines
• The facility will currently focus on manufacturing MAGNETOM Free.Star, a disruptively simple and helium-free approach to high-quality MRI

• The state-of-the-art technology is redefining the digital lab of the future

• Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite

• Highly flexible bi-plane positioning with seamlessly performing 2D and 3D acquisition using twin spin - a new intuitive model design that makes procedures fast

• Reaffirms our commitment to transforming care delivery in India, by improving access to high-quality healthcare for all
• Conceptualized, designed, and manufactured in India for the world, Cios Fit is a mobile C-arm designed for demanding multidisciplinary environments in busy Operating Rooms

• The company inaugurated the new production line at the Bengaluru facility to manufacture Computed Tomography Scanners.
• The new facility is approved under the Radiology and Imaging Medical devices segment of the Production Linked Incentive (‘PLI’) Scheme by the Government of India (GoI) and the Department of Pharmaceuticals (‘DoP’)
• Committed investment of ₹ 91.9 Crores under the PLI scheme for the manufacture of Computed Tomography and Magnetic Resonance Imaging

• MAGNETOM Free.Star is a disruptively simple approach to MRI that transforms access to high-value care.

• NAEOTOM Alpha® is the world’s first photon-counting CT that provides high-resolution images at minimal dose, spectral information in every scan, and improved contrast at lower noise.

• Production capacity of 25 million tests per annum, that can be ramped up further if required

• MDX facility with core production area of around 9,500 sq. ft., is co-located in the Diagnostics facility spread over 50,000 sq. ft.

• Designed with high sensitivity, specificity, and inclusivity, varied molecular test kits are expected to be available in a phased manner, starting from September 2021

• Recognition is an outcome of an inclusive culture and people centric policies

• Identified among India’s 100 Best Companies to Work for 2021 

• The futuristic campus aims to intensify collaboration and creativity, coupled with environment-friendly, sustainable, energy-efficient solutions.

• When completed, the campus will be Healthineers’ largest site globally in terms of built-up area.

• With Corindus, Siemens Healthineers aims to drive cardiovascular interventions with robotic assistance
• Robot facilitates smart procedural automation, performing complex interventional cases with shorter time and better outcomes
• Address challenges like limited skilled manpower and clinical infrastructure for complex procedures

• Most significant investment in India of INR 1300 cr. over next 5 yrs
• Furthering our commitment to India, Siemens Healthineers plans to hire additional 1800 skilled digital tech experts in next 10 yrs
• Innovation hub to be housed in new campus, combining R&D & manufacturing, making India a center of competence for design & development of entry-level products

• Advanced applications enable precise lesion detection and characterization
• AI-powered tools help reduce exam burden and increase efficiency
• Lightweight, portable design allows easy transport and use across clinical departments

• The next-gen manufacturing facility with investment of 200 million, produces solutions in Diagnostic Imaging & Advanced Therapies
• Somatom go.Now & Somatom go.Up CT scanners are suited to newly established radiology departments & expanding institutions
• Integration of Manufacturing, Technology & Innovation facilities helps address future needs of customers

• Strategically collocated with the company’s R&D center to deliver value to customers faster
• Production of mobile c-arm Cios Fit and CT systems from the Somatom go. platform for Indian and other emerging markets 
• Will start with around 70 employees, workforce will be extended in three phases by fiscal year 2025

• Apollo Proton Cancer Centre, Chennai introduces South-Asia’s first digital PET/CT - Biograph Vision™
• The first of its kind digital PET/CT, verifying proton beam therapy and efficacy of treatment for various cancers at early stage
• Safeguarding patients from negative side effects, and saving costs with early response effectively detected